News und Analysen
Geschäftsjahr 2024/25: Sonova erzielt Marktanteilsgewinne in allen Geschäftsbereichen und kündigt bevorstehenden CEO-Wechsel an
EQS-News: RHÖN-KLINIKUM AG im ersten Quartal 2025 auf stabilem Kurs – Ausblick bestätigt
3 Mid-Cap Medical Stocks Outperforming the Market
While major market indexes like the S&P 500 have struggled to gain traction in 2025 and remain in the red YTD, certain pockets of the market are showing impressive strength. Several medical and
The Top-Ranked Insider Buys From April by Market Cap
Insiders are buying stock in 2025, and activity is not limited to a single sector or market cap. This article looks at the top three insider buys from April based on market cap and the number of
EQS-News: Sartorius-Aufsichtsrat verlängert Bestellung von Vorstandsmitglied Alexandra Gatzemeyer
EQS-HV: Gerresheimer AG: Bekanntmachung der Einberufung zur Hauptversammlung am 05.06.2025 in Düsseldorf mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG
EQS-News: Gerresheimer: Broad Support from Creditors / Creditors agree to extend the due date / Sales process for Centor Inc. launched as planned
EQS-Adhoc: Gerresheimer AG: Creditors agree to extend the due date for submitting the audited 2025 annual and consolidated financial statements
EQS-News: Sartorius AG Supervisory Board extends appointment of board member René Fáber
EQS-News: Sartorius AG - Resolutions of the Annual General Meeting
EQS-News: RHÖN-KLINIKUM AG with consistent development in financial year 2025
This $7 Million Masimo Exit Came Before a 34% Surge on $9.9 Billion Acquisition
On February 17, 2026, Bridger Management disclosed in a Securities and Exchange Commission (SEC) filing that it sold out its entire position in Masimo (NASDAQ:MASI).
According to a Securities and
What Investors Should Know About a $24 Million Exit From a Medical Device Stock Down 9% This Past Year
Invenomic Capital Management fully exited its position in Haemonetics Corporation (NYSE:HAE), according to a February 17, 2026, SEC filing, selling 498,317 shares previously worth $24.29 million.
EQS-News: Sartorius sharpens strategy with biopharma focus and sets new mid-term growth targets
EQS-News: Sartorius launches next-generation platform to boost efficiency in cell therapy production
This Fund Built a $26 Million Stake in a Medical Tech Stock That's Soaring After a $9.9 Billion Deal Announcement
On February 17, 2026, Parkman Healthcare Partners disclosed a new position in Masimo Corporation (NASDAQ:MASI), acquiring 200,000 shares in the fourth quarter worth an estimated $26.01 million at
Hedge Fund Boone Capital Initiated a Stake in HealthEquity. Is the Stock a Buy?
According to a U.S. Securities and Exchange Commission (SEC) filing dated February 17, 2026, Boone Capital Management established a new position in HealthEquity by purchasing 212,856 shares. The
EQS-Adhoc: Gerresheimer AG: Publication of the 2025 annual and consolidated financial statements only after March 31, 2026, exclusion from the SDAX, postponement of the Annual General Meeting
EQS-Adhoc: Gerresheimer AG: BaFin announces expansion of audit of 2024 consolidated financial statements and initiation of audit of 2025 Half-Year Financial Report
Naya Capital Adds Masimo Shares
According to an SEC filing dated Feb. 18, Naya Capital Management UK Ltd disclosed a new position in Masimo (NASDAQ:MASI), acquiring nearly 1.6 million shares.
Masimo is a leading provider of
Chemed Stock Down 15% in a Year as One Fund Builds a $5.56 Million Stake
On February 12, 2026, Barington Companies Management disclosed a new position in Chemed (NYSE:CHE), acquiring 13,000 shares in an estimated $5.56 million trade.
According to an SEC filing dated
Director Sells GKOS 15,000 Shares for $1.9 Million
Marc Stapley, a director at Glaukos Corporation (NYSE:GKOS), executed a direct sale of 15,000 shares for a transaction value of approximately $1.9 million on Jan. 22, 2026, following the exercise of
Premier Path Loads Up ACWX With 64,000 Shares Bought
On January 22, 2026, Premier Path Wealth Partners, LLC disclosed a purchase of 64,073 shares of iShares Trust - iShares MSCI ACWI ex U.S. ETF (NASDAQ:ACWX), an estimated $4.25 million trade based on
Is Insulet (PODD) the Future of Diabetes Management?
Explore the exciting world of Insulet (NASDAQ: PODD) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market
EQS-Adhoc: RHÖN-KLINIKUM Aktiengesellschaft adjusts the EBITDA forecast for financial year 2025